Stroke Prevention Trial Comparing Rivaroxaban To Aspirin At Preventing Another Stroke In Patients Who Recently Had A Stroke Of Undetermined Cause.
Posted Date: May 15, 2019
- Investigator: Dawn Kleindorfer
- Type of Study: Drug
The purpose of this study is to compare two drugs in preventing blood clots, rivaroxaban and aspirin. The study drug rivaroxaban/Xarelto? has not yet been approved by the Federal Drug Administration (FDA) for secondary prevention of blood clots in the brain (stroke) and prevention of systemic e
Criteria:
We Are Asking You To Take Part In This Research Study Because You Are 18 Years Of Age Or Older And Y
Keywords:
Cerebrovascular Acci, Rivaroxaban, Stroke, Blood Clot, Aspirin
For More Information:
Alisha Hodge, Rn, Bsn
(513) 558-5149
alisha.hodge@uc.edu